Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
- Status
- RECRUITING
- Phase
- N/A
Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
First in Human Study of QLS5316 in Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
First in Human Study of SIM0610 in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)
- Status
- RECRUITING
- Phase
- PHASE4
Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
- Status
- RECRUITING
- Phase
- PHASE4
A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1